ArticleFrontiers in cell and developmental biology2026

A novel kinase inhibitor, Regorafenib, blocks EGFR-dependent signaling to repress tumour metastasis in human triple-negative breast cancers.

Ludong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.